TargetMol

PDAT

Product Code:
 
TAR-T24604
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24604-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24604-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24604-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
PDAT is a noncompetitive Indolethylamine N-methyltransferase inhibitor.
CAS:
1226213-83-7
Formula:
C15H23N3
Molecular Weight:
245.37
Purity:
0.98
SMILES:
CN(C)CCCNCCc1c[nH]c2ccccc12

References

1. Farrag NS, Cheskin LJ, Farag MK. A systematic review of childhood obesity in the Middle East and North Africa (MENA) region: Prevalence and risk factors meta-analysis. Adv Pediatr Res. 2017;4. pii: 8. doi: 10.12715/apr.2017.4.8. Epub 2017 Jun 15. PubMed PMID: 29354689; PubMed Central PMCID: PMC5773115. 2. Budiningsari D, Shahar S, Abdul Manaf Z, Mohd Nordin NA, Susetyowati S. Evaluation of Pictorial Dietary Assessment Tool for Hospitalized Patients with Diabetes: Cost, Accuracy, and User Satisfaction Analysis. Nutrients. 2017 Dec 28;10(1). pii: E27. doi: 10.3390/nu10010027. PubMed PMID: 29283401; PubMed Central PMCID: PMC5793255. 3. Farrag NS, Cheskin LJ, Farag MK. A systematic review of childhood obesity in the Middle East and North Africa (MENA) region: Health impact and management. Adv Pediatr Res. 2017;4. pii: 6. doi: 10.12715/apr.2017.4.6. Epub 2017 May 15. PubMed PMID: 29104941; PubMed Central PMCID: PMC5667657. 4. Krysta K, Krzystanek M, Cuba?a WJ, Wiglusz MS, Jakuszkowiak-Wojten K, Ga?uszko-W?gielnik M, Czarnowska-Cuba?a M, Szarmach J, W?odarczyk A, Janas-Kozik M. Telepsychiatry and Virtual Reality an the Teatment of Patients with Intellectual and Developmental Disabilities. Psychiatr Danub. 2017 Sep;29(Suppl 3):656-659. PubMed PMID: 28953847.